The risk of mortality in lymph node-negative APOA1 rs670 A/A carrying breast cancer patients was also higher than APOA1 rs670 G/G counterparts (HR=9.87, 95% CI=1.60-60.81, p=0.014). This evidence concerns the gene APOA1 and breast cancer.